The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10621 malaria professionals are enjoying the free benefits of MalariaWorld today

rhesus monkeys

Open Access | Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion

September 8, 2011 - 08:40 -- Patrick Sampao
Author(s): 
Joanne M. Lumsden, Sathit Pichyangkul, Anjali Yadava, et al.
Reference: 
Infection and Immunity, September 2011,p. 3492-3500, Vol. 79, No. 9

In this study rhesus monkeys were immunized intramuscularly three times with VMP001 in combination with a stable emulsion (SE) or a synthetic Toll-like receptor 4 (TLR4) agonist (glucopyranosyl lipid A [GLA]) in SE (GLA-SE).

Medical Condition: 
Medical Treatment: 

Open Access | Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion

August 17, 2011 - 09:37 -- Patrick Sampao
Author(s): 
Joanne M. Lumsden, Sathit Pichyangkul, Anjali Yadava, et al.
Reference: 
Infect. Immun., Sep 2011; 79: 3492 - 3500.

In this study rhesus monkeys were immunized intramuscularly three times with VMP001 in combination with a stable emulsion (SE) or a synthetic Toll-like receptor 4 (TLR4) agonist (glucopyranosyl lipid A [GLA]) in SE (GLA-SE).

Medical Condition: 
Medical Treatment: 
Subscribe to RSS - rhesus monkeys